A groundbreaking milestone has been reached in the fight against malaria. Novartis announced today that its revolutionary therapy has received formal approval to address malaria in newborns and infants, marking a https://nelsonhmet003790.pointblog.net/significant-approval-for-novartis-s-malaria-treatment-in-newborns-and-infants-81841668